Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Estimates of body composition with dual-energy X-ray absorptiometry in adults.

Li C, Ford ES, Zhao G, Balluz LS, Giles WH.

Am J Clin Nutr. 2009 Dec;90(6):1457-65. doi: 10.3945/ajcn.2009.28141. Epub 2009 Oct 7.

2.

Apoptosis: a clinically useful measure of antiretroviral drug toxicity?

Hooker DJ, Cherry CL.

Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1543-53. doi: 10.1517/17425250903282781. Review.

PMID:
19785516
3.

Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

Cockerham L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, Grunfeld C, Shlipak M, Tien PC.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):102-6. doi: 10.1097/QAI.0b013e3181b79d22.

4.

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

Ribera E, Paradiñeiro JC, Curran A, Sauleda S, García-Arumí E, Castella E, Puiggròs C, Crespo M, Feijoo M, Diaz M, Del Saz SV, Planas M, Sureda D, Falcó V, Ocaña I, Pahissa A.

HIV Clin Trials. 2008 Nov-Dec;9(6):407-17. doi: 10.1310/hct0906-407.

PMID:
19203906
5.

Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects.

Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Punyanitya M, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection.

Am J Clin Nutr. 2008 Oct;88(4):1088-96.

6.

Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy.

Crane HM, Grunfeld C, Harrington RD, Uldall KK, Ciechanowski PS, Kitahata MM.

HIV Med. 2008 Oct;9(9):780-6. doi: 10.1111/j.1468-1293.2008.00631.x. Epub 2008 Aug 27.

7.

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.

Valantin MA, Lanoy E, Bentata M, Kalmykova O, Boutekadjirt A, Allavena C, Rozenbaum W, Peytavin G, Amellal B, Calvez V, Costagliola D, Katlama C; NoNuke ANRS 108 Study Team.

HIV Med. 2008 Oct;9(8):625-35. doi: 10.1111/j.1468-1293.2008.00606.x. Epub 2008 Jul 8.

8.

Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaras K; Working Group 1.

Circulation. 2008 Jul 8;118(2):e20-8. doi: 10.1161/CIRCULATIONAHA.107.189623. Epub 2008 Jun 19. No abstract available.

9.

The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.

Wohl D, Scherzer R, Heymsfield S, Simberkoff M, Sidney S, Bacchetti P, Grunfeld C; FRAM Study Investigators.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):44-52. doi: 10.1097/QAI.0b013e31816d9ba1.

10.

Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women.

Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC; Fat Redistribution and Metabolic Changes in HIV Infection Study Investigators.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):35-43. doi: 10.1097/QAI.0b013e318164227f.

11.

The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy.

Madruga JR, Cassetti I, Suleiman JM, Etzel A, Zhong L, Holmes CB, Cheng AK, Enejosa J; Study 903E Team.

HIV Clin Trials. 2007 Nov-Dec;8(6):381-90.

PMID:
18042503
12.

Relationship of fat distribution with adipokines in human immunodeficiency virus infection.

Kosmiski LA, Bacchetti P, Kotler DP, Heymsfield SB, Lewis CE, Shlipak MG, Scherzer R, Grunfeld C.

J Clin Endocrinol Metab. 2008 Jan;93(1):216-24. Epub 2007 Oct 16.

13.

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

Tebas P, Zhang J, Yarasheski K, Evans S, Fischl MA, Shevitz A, Feinberg J, Collier AC, Shikuma C, Brizz B, Sattler F; AIDS Clinical Trials Group (ACTG).

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):193-200.

14.

Switching strategies to improve lipid profile and morphologic changes.

Barragan P, Fisac C, Podzamczer D.

AIDS Rev. 2006 Oct-Dec;8(4):191-203. Review.

PMID:
17219734
15.

Relation of stavudine discontinuation to anthropometric changes among HIV-infected women.

Tien PC, Schneider MF, Cole SR, Justman JE, French AL, Young M, DeHovitz J, Nathwani N, Brown TT.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):43-8.

PMID:
17091021
16.

Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.

Brown T, Wang Z, Chu H, Palella FJ, Kingsley L, Witt MD, Dobs AS.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):356-62. Erratum in: J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):119. Chu, Haito [corrected to Chu, Haitao].

PMID:
16980910
17.

Fat distribution in women with HIV infection.

Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):562-71.

18.

The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C.

Am J Epidemiol. 2006 May 1;163(9):860-9. Epub 2006 Mar 8.

19.

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.

Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J.

Pharmacotherapy. 2006 Feb;26(2):154-61.

PMID:
16466321
20.

Fat distribution in men with HIV infection.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, Saag M, Scherzer R, Shlipak M, Tien P; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):121-31.

Supplemental Content

Support Center